Evaluation of a protocol to control utilization of B-type natriuretic peptide testing

American Journal of Clinical Pathology

Volumn 126, Issue 2, 2006, Pages 190-194

  Lum, Gifford ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

B type natriuretic peptide; BNP; CHF; Congestive heart failure; Serial BNP; Utilization protocol

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CLINICAL PROTOCOL; CONGESTIVE HEART FAILURE; COST; EMERGENCY WARD; HEALTH CARE FACILITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; UNITED STATES;

EID: 33746752110     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/4X8HVJFKPHXJYMFK     Document Type: Article

References (22)

1. deLemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003;362:316-322.
2. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
3. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J. 2005;26:1115-1140.
4. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647-654.
5. Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol. 2001;37:379-385.
6. Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J. 2003;24;1710-1718.
7. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002;106:416-422.
8. Latini R, Masson S, de Angelis N, et al. Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts. J Card Fail. 2002;8:288-299.
9. Nieminen MS, Böhm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:384-416.
10. ACC/AHA. 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure; developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation; endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154-e235. Available at http://www.acc.org/clinical/guidelines/failure/index.pdf. Accessed June 14, 2006.
11. Silver MA, Maisel A, Yancy CW, et al. BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail. 2004;10(suppl 3):1-30.
12. O'Connell JB. The economic burden of heart failure. Clin Cardiol. 2000;23(suppl III);III6-III10.
13. Haldeman GA, Croft JB, Giles WH, et al. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J. 1999;137:352-360.
14. College of American Pathologists. Survey 2003: B-Type Natriuretic Peptides (BNP and NT-proBNP). Northfield, IL: College of American Pathologists; 2003.
15. College of American Pathologists. Survey 2004: B-Type Natriuretic Peptides (BNP and NT-proBNP). Northfield, IL: College of American Pathologists; 2004.
16. College of American Pathologists. Survey 2005: B-Type Natriuretic Peptides (BNP and NT-proBNP). Northfield, IL: College of American Pathologists; 2005.
17. Yandle T, Fisher S, Livesey J, et al. Exponential increase in clinical use of plasma brain natriuretic peptide (BNP) assays. N Z Med J. 2004;117:U956.
18. Harrison A, Bhalla V, Gardetto N, et al. Evolving use of B-type natriuretic peptide in clinical practice [letter]. Clin Chem. 2004;50:1714-1715.
19. Apple FS, Trinity E, Steen J, et al. BNP test utilization for CHF in community hospital practice. Clin Chim Acta. 2003;328:191-193.
20. Heeschen C, Hamm CW, Mitrovic V, et al. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation. 2004;110:3206-3212.
21. Morrow DA, de Lemos JA, Blazing MA, et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. JAMA. 2005;294:2866-2871.
22. Doust JA, Pietrzak E, Dobson A, et al. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ. 2005;330:625.